To join a lawsuit over a defective artificial joint, you typically need to file an individual claim through a mass tort attorney rather than sign up for a traditional class action. Most defective joint litigation is handled through multidistrict litigation, where individual cases are consolidated before a single federal judge for pretrial proceedings but each plaintiff maintains their own claim. The distinction matters because your compensation depends on the specifics of your injury, not a blanket settlement split among all members of a class. The largest active consolidation right now is Exactech MDL 3044, where 1,838 lawsuits are pending before Judge Nicolas Garaufis in the U.S.
District Court for the Eastern District of New York as of February 2026. Exactech recalled over 200,000 ankle, knee, and hip joint implants — roughly 657,391 devices total — after discovering that defective packaging caused polyethylene insert components to degrade before they were even implanted. If you received an Exactech joint replacement and later needed revision surgery, you may qualify to file a claim in this MDL, and most attorneys handling these cases work on contingency, meaning no upfront cost to you.
Table of Contents
- What Does It Take to Qualify for a Defective Artificial Joint Lawsuit?
- Understanding the MDL Process and Why These Aren’t Traditional Class Actions
- Major Manufacturers and the Scale of Defective Joint Litigation
- Steps to Take Right Now If You Suspect Your Joint Implant Is Defective
- The Regulatory Gaps That Let Defective Implants Reach Patients
- What Happens If the Manufacturer Files for Bankruptcy
- The Outlook for Defective Joint Litigation in 2026 and Beyond
- Frequently Asked Questions
What Does It Take to Qualify for a Defective Artificial Joint Lawsuit?
The general qualification criteria across most defective joint litigation follow a consistent pattern. you typically need to show three things: that you required revision surgery due to a specific implant failure such as fracture, corrosion, component disassociation, or metal wear; that the failure occurred less than 13 years after your initial implantation; and that you have supporting documentation including surgical records, implant identification stickers, or revision surgery reports. That last requirement trips up more people than you might expect — many patients leave the hospital after joint replacement without ever receiving a copy of their implant card or device identification number. The 13-year window is worth paying attention to. Artificial joints are marketed as lasting 15 to 20 years, so a failure within 13 years suggests a defect rather than normal wear. However, if your implant failed at year 14 or 15, that does not automatically disqualify you.
Attorneys evaluate each case individually, and there may be evidence that your specific device had a known defect regardless of when it failed. The key is whether the failure can be attributed to a manufacturing or design problem rather than patient-specific factors like infection or trauma. Documentation is where many potential plaintiffs lose ground. If you had revision surgery, contact the hospital or surgical center where both your original implantation and your revision were performed. Request your complete operative reports, implant identification records, and any correspondence you received about device recalls. Attorneys handling these cases on contingency — meaning they collect a percentage of your settlement only if you win — will generally help you obtain medical records, but having your own copies speeds up the intake process significantly.
Understanding the MDL Process and Why These Aren’t Traditional Class Actions
When people hear about lawsuits involving thousands of plaintiffs, they assume it is a class action. In defective joint litigation, that is almost never the case. These cases are organized as mass torts consolidated into multidistrict litigation. The practical difference is significant: in a class action, one or a few named plaintiffs represent everyone, and any settlement is divided among the entire class. In an MDL, each plaintiff files their own individual lawsuit, but a judicial panel transfers all the federal cases to a single judge for coordinated pretrial work like discovery and motion practice. If the cases do not settle, they get sent back to their original courts for individual trials.
This structure benefits plaintiffs with severe injuries because your settlement amount reflects your specific damages — your medical bills, lost wages, pain, and number of revision surgeries — rather than being diluted across thousands of claims. In the Exactech MDL 3044, estimated settlement values range between $50,000 and $300,000 per case depending on the severity of complications and the extent of documented damages. No trials or approved settlements have occurred yet in this MDL, so those figures are projections based on comparable litigation. However, if Exactech’s October 2024 Chapter 11 bankruptcy filing complicates the process, plaintiffs could face delays. Exactech filed for bankruptcy protection in Delaware on October 29, 2024, citing mounting legal costs, and Judge Garaufis ordered a stay on proceedings just three days later on November 1, 2024. The court continues accepting new transferred cases, but the bankruptcy creates uncertainty about the timeline and potentially the total funds available for settlements. The company’s estimated assets sit between $100 million and $500 million — a wide range that leaves open questions about whether all plaintiffs will receive full compensation.
Major Manufacturers and the Scale of Defective Joint Litigation
Exactech is far from the only manufacturer facing massive liability. DePuy, a Johnson & Johnson subsidiary, has paid over $4 billion in settlements across approximately 20,000 separate claims related to its Pinnacle and ASR hip replacement products. Those settlements rank among the largest in medical device history and set the benchmark that attorneys now use when projecting outcomes in newer litigation. Stryker faces ongoing lawsuits on multiple fronts. Its Rejuvenate and ABG II hip stems still have 42 active lawsuits pending as of October 2025.
Meanwhile, Stryker’s Cartiva Synthetic Cartilage Implant — used for toe joint arthritis — was recalled for all units sold since July 2016 after patients reported higher-than-expected rates of persistent pain, nerve damage, and implant fragmentation. A trial date in the Cartiva litigation has been potentially pushed to August 17, 2026, which means plaintiffs in that case are looking at years from injury to any potential resolution. Zimmer Biomet issued a voluntary recall on July 2, 2024 for its CPT Hip System Femoral Stem 12/14 Neck Taper due to mechanical failure. The FDA followed up with a warning on September 17, 2024, citing a higher fracture risk compared to similar devices on the market. Across the entire industry, hip replacement companies alone have paid more than $7 billion in settlements over the years. That number continues to grow as new recalls emerge and more patients come forward.
Steps to Take Right Now If You Suspect Your Joint Implant Is Defective
If you are experiencing unusual pain, swelling, instability, or reduced mobility in an artificial joint, the first step is not calling a lawyer — it is seeing your orthopedic surgeon. You need a current medical evaluation that documents your symptoms and, if warranted, imaging that shows the condition of your implant. An attorney cannot build a case without medical evidence, and a surgeon’s documentation of implant failure is the foundation of any claim. Once you have a medical assessment, gather every record related to your original surgery. This includes the operative report, the implant identification card (often given to patients at discharge), any follow-up visit notes, and particularly any recall notices you may have received.
Exactech, for example, sent recall notifications to surgeons who performed the implantations, but not every patient was successfully contacted. Check the FDA’s medical device recall database directly if you are unsure whether your implant has been recalled. The tradeoff between filing individually versus waiting for an MDL settlement structure to emerge is worth considering. Filing early means your case is documented and in the system, but it also means potentially longer wait times if the litigation is still in its early stages. Filing later risks running into statute of limitations issues, which vary by state — some states give you as little as two years from the date you discovered (or should have discovered) the defect. In general, filing sooner is safer, and since most firms work on contingency, there is no financial penalty for getting your claim on record early.
The Regulatory Gaps That Let Defective Implants Reach Patients
The FDA’s approval pathways for medical devices have been criticized for decades, and the numbers back up those concerns. A December 2025 report from the U.S. Government Accountability Office found that nearly 4,000 medical devices needed to be recalled between 2020 and 2024. More than 10 percent of orthopedic devices approved by either FDA pathway — the rigorous premarket approval process or the faster 510(k) clearance route — were eventually recalled. The American Academy of Orthopaedic Surgeons maintains a dashboard tracking over 90 active recalls of orthopedic devices. These figures reveal a systemic problem rather than isolated incidents.
The 510(k) pathway, which allows manufacturers to bring devices to market by showing they are “substantially equivalent” to something already approved, does not require clinical trial data. That means a joint implant can reach hundreds of thousands of patients based on a paper comparison to a predicate device rather than evidence from actual human testing. Exactech’s case is particularly damning: the company paid $8 million to resolve U.S. government allegations that it knowingly sold defective implants to Medicare, Medicaid, and the VA despite knowing since 2006 that some components had high failure rates. For patients, the warning is straightforward: a device being FDA-cleared does not guarantee it is safe or effective in the way most people assume. If you are considering joint replacement surgery, ask your surgeon specifically which device they plan to use, whether it has been subject to any recalls or FDA warnings, and what the published failure rates are for that specific implant model.
What Happens If the Manufacturer Files for Bankruptcy
Exactech’s Chapter 11 filing on October 29, 2024 raised immediate alarm among plaintiffs with pending claims. Bankruptcy does not mean the company disappears or that lawsuits vanish — Chapter 11 is a reorganization, not a liquidation. The company continues operating while it restructures its debts, and the bankruptcy court must account for tort claimants in the reorganization plan.
With estimated assets between $100 million and $500 million, Exactech likely has resources to fund settlements, but the bankruptcy process adds layers of complexity and delay that can stretch timelines by a year or more. For comparison, other medical device and pharmaceutical companies that filed for bankruptcy during mass tort litigation — including certain talc and opioid defendants — established dedicated settlement trusts funded during the reorganization. Whether Exactech follows a similar path will depend on negotiations between the company, its creditors, and the plaintiffs’ steering committee in MDL 3044. If you have a pending Exactech claim, your attorney should be monitoring the bankruptcy proceedings in Delaware alongside the MDL in New York.
The Outlook for Defective Joint Litigation in 2026 and Beyond
As of January 2026, no active knee replacement MDLs exist in federal courts beyond Exactech, but that could change quickly. The Zimmer Biomet CPT Hip System recall is relatively fresh, and the Stryker Cartiva trial potentially set for August 2026 could produce a verdict that reshapes settlement calculations across the entire orthopedic device industry. New recalls continue to emerge at a steady pace, and the GAO’s findings about the scale of device failures suggest more litigation is on the horizon rather than less.
The broader trend points toward increased scrutiny of orthopedic device manufacturers from both regulators and courts. With industry-wide settlements already exceeding $7 billion and multiple active recalls in play, manufacturers face growing pressure to improve post-market surveillance and respond more quickly when failure signals emerge. For patients with failing implants, the message is clear: document everything, consult both a surgeon and an attorney, and do not assume that someone else will notify you if your device has been recalled.
Frequently Asked Questions
Is there a deadline to file a claim for a defective artificial joint?
Yes, but it varies by state. Statutes of limitations for product liability claims typically range from two to four years, usually starting from the date you discovered or should have discovered the defect. Some states also have a statute of repose that sets an absolute outer deadline regardless of when you discovered the problem. Consult an attorney in your state promptly to avoid missing your window.
Do I need to pay anything upfront to join a defective joint lawsuit?
In almost all cases, no. Attorneys handling defective joint litigation work on contingency, meaning they take a percentage of your settlement or verdict — typically between 33 and 40 percent — and you pay nothing if there is no recovery. You should confirm the fee structure in writing before signing a retainer agreement.
What if my implant failed but I haven’t had revision surgery yet?
Most defective joint claims require evidence of revision surgery or documented implant failure. If your surgeon has recommended revision but you have not yet undergone it, consult with an attorney about whether you can file a claim based on the recommendation and supporting imaging. However, cases with completed revision surgery and clear documentation of implant failure are significantly stronger.
How much compensation can I expect from a defective joint lawsuit?
It depends heavily on your specific circumstances. In the Exactech MDL, estimated settlement values range between $50,000 and $300,000 per case depending on the severity of complications and extent of damages. DePuy’s Pinnacle and ASR hip settlements averaged out differently across their roughly 20,000 claims. Your individual compensation depends on factors like the number of revision surgeries, medical expenses, lost income, and ongoing pain.
Does Exactech’s bankruptcy mean I can’t file a claim anymore?
No. Exactech filed for Chapter 11 reorganization, not liquidation. The MDL court continues accepting new transferred cases even after the November 2024 stay. The bankruptcy process may delay resolution, but it does not eliminate your ability to file or recover compensation. A settlement trust may be established as part of the reorganization.
How do I find out if my specific implant has been recalled?
Check the FDA’s medical device recall database at fda.gov using your implant’s model name or manufacturer. You can also contact the hospital where your surgery was performed to request your implant identification records. Your orthopedic surgeon’s office may have received recall notices directly from the manufacturer.
You Might Also Like
- How to Join a Class Action Lawsuit for Contaminated IV Saline
- How to Join a Class Action Against a Pharmaceutical Company
- How to Find Class Action Lawsuits for Defective Medical Implants